Company Filing History:
Years Active: 1977
Title: Kay H Boswell: Innovator in Purine Derivatives
Introduction
Kay H Boswell, an esteemed inventor based in Mission Viejo, California, has made notable contributions to the field of biochemical innovations. With a focus on purine derivatives, her research has led to the development of two patented inventions that exhibit significant therapeutic potential.
Latest Patents
Kay H Boswell holds two patents, the latest being centered on 6,8-Disubstituted purine derivatives of 9-β-D-ribofuranosyl. This patent details compounds characterized by a complex formula, wherein various substituents such as --NR₁R₂, --Cl, and --Br contribute to their biochemical functionalities. These compounds are known to exhibit properties such as phosphodiesterase inhibition, protein kinase activation, and positive inotropic effects, making them valuable for a range of biological applications.
Additionally, her other patent focuses on 6-Aminocarbonyl purine 3',5'-cyclic nucleotides. These innovative compounds, including N⁶-Carbamoyl and -carbonyl analogs of adenosine 3',5'-cyclic phosphate (cAMP), are recognized for their superior activation of kinase, inhibition of phosphodiesterase, and potential to enhance cardiac output or lower blood pressure.
Career Highlights
Kay is currently associated with Icn Pharmaceuticals, Inc., where she applies her expertise to further advancements in pharmaceuticals. Her work in the development of purine derivatives showcases her dedication to improving therapeutic strategies in medicine.
Collaborations
Throughout her career, Kay has collaborated with notable colleagues such as Roland K Robins and Dennis A Shuman. These partnerships have fostered an environment of innovation, enabling the successful progression of her research endeavors.
Conclusion
Kay H Boswell stands out as a pioneering figure in the realm of purine derivative inventions. Her contributions continue to pave the way for enhanced therapeutic options, reflecting her commitment to innovation in biochemistry. As the industry evolves, her research remains integral to discovering new solutions for health challenges.